Triple Combo of Proteostasis’ CFTR Modulators May Benefit CF Patients, Phase 1 Trial Shows
Mar 27, 2019 07:00 am | Alice Melão
Treatment with Proteostasis Therapeutics’ triple combo therapy regimen may significantly improve the lung function of patients with cystic fibrosis (CF), results from a Phase 1 clinical trial suggest. The therapy includes the company’s three investigational modulators of the CFTR gene: PTI-428, which is an amplifier; PTI-801, which is a corrector; and PTI-808, which is a potentiator. This combination is designed to overcome the […]
The post Triple Combo of Proteostasis’ CFTR Modulators May Benefit CF Patients, Phase 1 Trial Shows appeared first on Cystic Fibrosis News Today. |
|
|
‘CFer’ or ‘Person with CF’? I’m a CFer and Proud of It
Mar 26, 2019 09:00 am | Brad Dell
Note: I do not write on behalf of the entire CF community. No one does. This is about my preference. The most amusing, yet irritating, thing a person without chronic conditions can do to me is correct the language I use to talk about myself. “Oh, shouldn’t you say ‘person with deafness’ instead of ‘Deaf‘?” […]
The post ‘CFer’ or ‘Person with CF’? I’m a CFer and Proud of It appeared first on Cystic Fibrosis News Today. |
|
|
Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows
Mar 26, 2019 07:00 am | Ana Pena
Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for treating lung allergic reactions caused by fungi in patients with cystic fibrosis (CF), a case report suggests. The study reports three cases of allergic bronchopulmonary aspergillosis in CF patients who were successfully treated with Xolair after conventional therapy with corticosteroids and […]
The post Asthma Medicine Xolair Successfully Treats Lung Allergy Due to Fungal Infection in 3 CF Patients, Case Report Shows appeared first on Cystic Fibrosis News Today. |
|
|
|
Treatment with Proteostasis Therapeutics’ triple combo therapy regimen may significantly improve the lung function of patients with cystic fibrosis (CF), results from a Phase 1 clinical trial suggest. The therapy includes the company’s three investigational modulators of the CFTR gene: PTI-428, which is an amplifier; PTI-801, which is a corrector; and PTI-808, which is a potentiator. This combination is designed to overcome the […]
Note: I do not write on behalf of the entire CF community. No one does. This is about my preference. The most amusing, yet irritating, thing a person without chronic conditions can do to me is correct the language I use to talk about myself. “Oh, shouldn’t you say ‘person with deafness’ instead of ‘Deaf‘?” […]
Xolair (omalizumab), a medicine used for allergic asthma and chronic hives, is effective for treating lung allergic reactions caused by fungi in patients with cystic fibrosis (CF), a case report suggests. The study reports three cases of allergic bronchopulmonary aspergillosis in CF patients who were successfully treated with Xolair after conventional therapy with corticosteroids and […]
No hay comentarios:
Publicar un comentario